Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ku70/XRCC6 Expression in Waldenström's Macroglobulinemia
NCT02640287Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Feb 2016
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Measure of ratio Ku70/XRCC6. Started Feb 2016; status: completed.
Beyond the preview
Go deeper on NCT02640287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02640287.